大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/29 | 1,930 | 2,250 | 1,928 | 2,247 | +317 | +16.4% | 5,086,300 |
2020/05/28 | 1,877 | 1,938 | 1,862 | 1,930 | +90 | +4.9% | 1,235,200 |
2020/05/27 | 1,762 | 1,863 | 1,735 | 1,840 | +71 | +4% | 963,700 |
2020/05/26 | 1,842 | 1,844 | 1,732 | 1,769 | -66 | -3.6% | 1,247,200 |
2020/05/25 | 1,847 | 1,850 | 1,782 | 1,835 | -18 | -1% | 778,800 |
2020/05/22 | 1,880 | 1,894 | 1,845 | 1,853 | -27 | -1.4% | 529,300 |
2020/05/21 | 1,873 | 1,886 | 1,836 | 1,880 | +2 | +0.1% | 557,700 |
2020/05/20 | 1,881 | 1,915 | 1,855 | 1,878 | +11 | +0.6% | 683,200 |
2020/05/19 | 1,940 | 1,940 | 1,821 | 1,867 | -86 | -4.4% | 1,275,600 |
2020/05/18 | 1,923 | 1,963 | 1,895 | 1,953 | +29 | +1.5% | 997,900 |
2020/05/15 | 1,811 | 1,931 | 1,811 | 1,924 | +104 | +5.7% | 1,544,800 |
2020/05/14 | 1,851 | 1,869 | 1,784 | 1,820 | -38 | -2% | 1,160,000 |
2020/05/13 | 1,739 | 1,909 | 1,735 | 1,858 | +56 | +3.1% | 2,491,000 |
2020/05/12 | 1,769 | 1,829 | 1,733 | 1,802 | +96 | +5.6% | 1,596,500 |
2020/05/11 | 1,753 | 1,755 | 1,653 | 1,706 | -22 | -1.3% | 946,100 |
2020/05/08 | 1,850 | 1,850 | 1,687 | 1,728 | -142 | -7.6% | 1,609,700 |
2020/05/07 | 1,719 | 1,894 | 1,719 | 1,870 | +167 | +9.8% | 1,455,000 |
2020/05/01 | 1,680 | 1,722 | 1,663 | 1,703 | +42 | +2.5% | 578,800 |
2020/04/30 | 1,800 | 1,803 | 1,650 | 1,661 | -127 | -7.1% | 1,201,100 |
2020/04/28 | 1,760 | 1,807 | 1,750 | 1,788 | +23 | +1.3% | 633,400 |
2020/04/27 | 1,820 | 1,830 | 1,751 | 1,765 | -50 | -2.8% | 838,000 |
2020/04/24 | 1,861 | 1,876 | 1,778 | 1,815 | -51 | -2.7% | 628,700 |
2020/04/23 | 1,880 | 1,880 | 1,828 | 1,866 | -6 | -0.3% | 474,100 |
2020/04/22 | 1,805 | 1,903 | 1,805 | 1,872 | +54 | +3% | 918,000 |
2020/04/21 | 1,866 | 1,908 | 1,818 | 1,818 | -29 | -1.6% | 521,000 |
2020/04/20 | 1,926 | 1,939 | 1,840 | 1,847 | -97 | -5% | 719,700 |
2020/04/17 | 1,968 | 1,974 | 1,911 | 1,944 | -12 | -0.6% | 686,900 |
2020/04/16 | 1,875 | 1,956 | 1,858 | 1,956 | +56 | +2.9% | 813,500 |
2020/04/15 | 1,933 | 1,934 | 1,835 | 1,900 | ±0 | ±0% | 805,300 |
2020/04/14 | 1,850 | 1,907 | 1,825 | 1,900 | +66 | +3.6% | 929,600 |
2020/04/13 | 1,778 | 1,884 | 1,761 | 1,834 | +34 | +1.9% | 936,500 |
2020/04/10 | 1,736 | 1,801 | 1,720 | 1,800 | +81 | +4.7% | 901,200 |
2020/04/09 | 1,707 | 1,736 | 1,652 | 1,719 | +3 | +0.2% | 614,200 |
2020/04/08 | 1,634 | 1,722 | 1,621 | 1,716 | +91 | +5.6% | 1,088,100 |
2020/04/07 | 1,625 | 1,656 | 1,580 | 1,625 | +1 | +0.1% | 507,500 |
2020/04/06 | 1,635 | 1,639 | 1,550 | 1,624 | +5 | +0.3% | 763,300 |
2020/04/03 | 1,537 | 1,630 | 1,537 | 1,619 | +80 | +5.2% | 709,300 |
2020/04/02 | 1,514 | 1,635 | 1,513 | 1,539 | +11 | +0.7% | 563,600 |
2020/04/01 | 1,521 | 1,581 | 1,511 | 1,528 | -28 | -1.8% | 493,700 |
2020/03/31 | 1,630 | 1,667 | 1,535 | 1,556 | -99 | -6% | 686,600 |
2020/03/30 | 1,600 | 1,682 | 1,570 | 1,655 | -3,045 | -64.8% | 869,500 |
2020/03/27 | 4,770 | 4,795 | 4,550 | 4,700 | +10 | +0.2% | 292,200 |
2020/03/26 | 4,290 | 4,760 | 4,200 | 4,690 | +330 | +7.6% | 414,100 |
2020/03/25 | 4,385 | 4,395 | 4,220 | 4,360 | +175 | +4.2% | 225,700 |
2020/03/24 | 4,255 | 4,350 | 4,080 | 4,185 | ±0 | ±0% | 335,000 |
2020/03/23 | 4,025 | 4,195 | 4,000 | 4,185 | +285 | +7.3% | 311,000 |
2020/03/19 | 4,215 | 4,250 | 3,900 | 3,900 | -135 | -3.3% | 381,200 |
2020/03/18 | 3,950 | 4,195 | 3,900 | 4,035 | +245 | +6.5% | 341,700 |
2020/03/17 | 3,420 | 3,905 | 3,405 | 3,790 | +130 | +3.6% | 407,200 |
2020/03/16 | 3,615 | 3,975 | 3,565 | 3,660 | +145 | +4.1% | 367,200 |
1101~
1150
件表示中 / 3839件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム